Demonstration of a Plasmatic Cofactor Different from Fibrinogen Necessary for Platelet Release by ADP and Adrenaline^[*]

Summary

Secondary wave production and release of platelet factor 4 were studied in washed platelet suspensions and citrate plasma. Induction of a secondary wave requires the presence of large aggregates and a plasmatic cofactor different from fibrinogen. Acetyl-salicylic acid inhibited the production of a second wave both in plasma and platelet suspensions. Plasma taken after the intake of acetyl-salicylic acid induced a second wave in platelets harvested before the intake. The possible production of thrombin or allied enzyme inside the platelet aggregates due to changed internal milieu is suggested as a possible cause of the release reaction induced by ADP and adrenaline. Fundamental differences existed between the release induced by ADP and adrenaline and that induced by collagen, kaolin and other particles.

^*) Supported by a grant from D. G. R. S. T. 68 01 317.

^**) Attaché de Recherche, I.N.S.E.R.M. Present address: Coagulation Laboratory, Allmanna Sjukhuset, 214 01 Malmö, Sweden.

^***) Attaché de Recherche, I.N.S.E.R.M. Present address: Hospital of Cadca, Cadca, Czechoslovakia.

• References

• 1 Al-Mondhiry H, Marcus A, Spaet T. H. Acétylation of human platelets by aspirin. Fed. Proc 28: 576 1969;
• 2 Breddin K, Bauke J. Thrombozytenagglntination und Gefäßkrankheiten. Blut 11: 144 1965;
• 3 Caen J, Michel H. L’activité agrégante du sérum (plasma défibriné par la thrombine). Rév. franç. Étud. clin. biol 09: 1001 1964;
• 4 Caen J. P, Cronberg S, Levy-Toledano S, Kubisz P, Pinkhas J. New data in Glanzmann’s thrombasthenia. Proc. Soc. exp. Biol. (N.Y). (In press.)
• 5 Cronberg S. Investigations in haemorrhagic disorders with prolonged bleeding time but normal number of platelets. Acta med. scand Suppl. 486 1968;
• 6 Cronberg S. Evaluation of platelet aggregation. Coagulation 03: 139 1970;
• 7 Cronberg S, Caen J. P. Platelet aggregation in washed suspensions. Scand. J. Haemat. (Submitted for publication.)
• 8 Cronberg S, Caen J. P. Release reaction in platelet suspensions induced by kaolin and other particles. Scand. J. Haemat. (Submitted for publication.)
• 9 Deykin D, Pritzker C. R, Scolnick E. M. Plasma cofactors in adenosine diphosphate-induced aggregation of human platelets. Nature (Lond) 208: 296 1965;
• 10 Grette K. Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets. Acta physiol, scand. 56. Suppl. 195 1962
• 11 Hardisty R. M, Hutton R. A. Platelet aggregation and the availability of platelet factor 3. Brit. J. Haemat 12: 764 1966;
• 12 Haslam R. J. Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature (Lond) 202: 765 1964;
• 13 Hellem A. J. The adhesiveness of human blood platelets in vitro. Scand. J. Lab. clin. Invest. 12. Suppl. 51 1960
• 14 Holdrinet H, Ewals M, Reichert W. J, Haanen C. Mathematical correlation between ADP- induced platelet aggregation and subsequent disaggregation. Scand. J. Haemat 06: 354 1969;
• 15 Holmsen H, Day H. J, Stormorken H. The blood platelet release reaction. Scand. J. Haemat. Suppl. 8 1969
• 16 Hovig T. Aggregation of rabbit blood platelets produced in vitro by “saline extract” of tendons. Thrombos. Diathes. haemorrh. (Stuttg) 09: 248 1963;
• 17 Legrand Y, Caen J. L’adhésion des plaquettes au collagène. jFirst Internat. Symp. on Tissue Factors in the Homeostasis on the Coagulation-fibrinolysis System. Florence; 193 1967
• 18 Macmillan D. G. Secondary clumping effect in human citrated platelet-rich plasma produced by ADP and adrenaline. Nature (Lond) 211: 140 1966;
• 19 Mills D. G, Robb I. A, Roberts G. G. A. The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation. J. Physiol 195: 715 1968;
• 20 Morris G. D. W. Acetylsalicylic acid and platelet stickiness. Lancet I: 279 1967;
• 21 Mustard J. F, Hegardt B, Rowsell H. G, MacMillan R. L. The effect of adenosine nucleotides on platelet aggregation and clotting time. J. Lab. clin. Med 64: 548 1964;
• 22 O’Brien J. R. Variability in the aggregation of human platelets by adrenaline. Nature (Lond) 202: 1188 1964;
• 23 O’Brien J. R. Effects of salicylates on human platelets. Lancet I: 779 1968;
• 24 O’Brien J. R, Shoobridge S. M, Finch W. J. Comparison of the effect of heparin and citrate on platelet aggregation. J. clin. Path 22: 28 1969;
• 25 Poplawski A, Niewiarowski S. Method for determining antiheparin activity of platelets and erythrocytes. Thrombos. Diathes. haemorrh. (Stuttg) 13: 149 1965;
• 26 Sahud M. A, Aggeler P. M. Platelet dysfunction - differentiation of a primary type from that produced by aspirin. New Engl. J. Med 280: 453 1969;
• 27 Weiss H. J, Aledort L. M. Impaired platelet/connective-tissue reaction in man after aspirin ingestion. Lancet II: 495 1967;
• 28 Wright H. P. The adhesiveness of blood platelets in normal subjects and with varying concentrations of anticoagulants. J. Path. Bact 53: 255 1941;
• 29 Youssef A. H, Barkhan P. Inhibition by aspirin of release of antiheparin activity from human platelets. Brit. med. J 03: 394 1969;
• 30 Zucker M. B, Peterson J. Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetyl-salicylic acid ingestion. Proc. Soc. exp. Biol. (N. Y.) 727: 547 1968;